DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,463,847 | -3.1% | 17,992 | -6.3% | 0.56% | +0.2% |
| Q2 2023 | $4,607,955 | -10.4% | 19,200 | -5.9% | 0.56% | -15.7% |
| Q1 2023 | $5,141,223 | -9.8% | 20,398 | -5.0% | 0.66% | -14.9% |
| Q4 2022 | $5,701,006 | +2.4% | 21,479 | -0.4% | 0.78% | -2.5% |
| Q3 2022 | $5,570,000 | -4.0% | 21,564 | -5.8% | 0.80% | +3.6% |
| Q2 2022 | $5,802,000 | -15.0% | 22,887 | -1.7% | 0.77% | -0.9% |
| Q1 2022 | $6,827,000 | -11.8% | 23,273 | -1.1% | 0.78% | -10.3% |
| Q4 2021 | $7,741,000 | +6.1% | 23,529 | -1.9% | 0.87% | -5.7% |
| Q3 2021 | $7,299,000 | +9.4% | 23,975 | -3.6% | 0.92% | +8.6% |
| Q2 2021 | $6,672,000 | +14.7% | 24,862 | -3.8% | 0.85% | +7.5% |
| Q1 2021 | $5,818,000 | +0.9% | 25,846 | -0.4% | 0.79% | -6.5% |
| Q4 2020 | $5,764,000 | -3.0% | 25,946 | -6.0% | 0.84% | -13.3% |
| Q3 2020 | $5,945,000 | +20.7% | 27,611 | -0.9% | 0.97% | +11.3% |
| Q2 2020 | $4,925,000 | +32.8% | 27,850 | +4.0% | 0.87% | +12.2% |
| Q1 2020 | $3,708,000 | -22.8% | 26,790 | -14.4% | 0.78% | +1.0% |
| Q4 2019 | $4,801,000 | +5.1% | 31,280 | -1.1% | 0.77% | -3.5% |
| Q3 2019 | $4,568,000 | +1.1% | 31,629 | +0.1% | 0.80% | -1.6% |
| Q2 2019 | $4,517,000 | +10.8% | 31,606 | +2.4% | 0.81% | +6.9% |
| Q1 2019 | $4,076,000 | +45.7% | 30,876 | +13.8% | 0.76% | +27.1% |
| Q4 2018 | $2,798,000 | +0.1% | 27,130 | +5.5% | 0.60% | +15.3% |
| Q3 2018 | $2,794,000 | +19.5% | 25,714 | +8.5% | 0.52% | +12.4% |
| Q2 2018 | $2,338,000 | +2.5% | 23,693 | +1.7% | 0.46% | -1.5% |
| Q1 2018 | $2,281,000 | +8.7% | 23,302 | +3.1% | 0.47% | +12.2% |
| Q4 2017 | $2,099,000 | +14.7% | 22,611 | +6.0% | 0.42% | +8.3% |
| Q3 2017 | $1,830,000 | +4.1% | 21,331 | +2.4% | 0.38% | +0.5% |
| Q2 2017 | $1,758,000 | +0.8% | 20,835 | +2.2% | 0.38% | -2.5% |
| Q1 2017 | $1,744,000 | +19.0% | 20,385 | +8.3% | 0.39% | +11.3% |
| Q4 2016 | $1,466,000 | +4.8% | 18,830 | +5.5% | 0.35% | +0.9% |
| Q3 2016 | $1,399,000 | -6.2% | 17,850 | +20.8% | 0.35% | -10.7% |
| Q2 2016 | $1,492,000 | +6.8% | 14,775 | +0.3% | 0.39% | +2.3% |
| Q1 2016 | $1,397,000 | +14.6% | 14,725 | +12.2% | 0.38% | +10.1% |
| Q4 2015 | $1,219,000 | +30.1% | 13,120 | +19.3% | 0.35% | +20.8% |
| Q3 2015 | $937,000 | +3.4% | 11,000 | +4.0% | 0.29% | +10.3% |
| Q2 2015 | $906,000 | +3.3% | 10,580 | +2.4% | 0.26% | +2.0% |
| Q1 2015 | $877,000 | +13.0% | 10,330 | +14.1% | 0.26% | +12.3% |
| Q4 2014 | $776,000 | +14.6% | 9,055 | +1.7% | 0.23% | +8.6% |
| Q3 2014 | $677,000 | -0.9% | 8,905 | +2.6% | 0.21% | -3.2% |
| Q2 2014 | $683,000 | +15.0% | 8,680 | +9.6% | 0.22% | +7.4% |
| Q1 2014 | $594,000 | -4.0% | 7,920 | -1.2% | 0.20% | -6.5% |
| Q4 2013 | $619,000 | +11.3% | 8,020 | 0.0% | 0.22% | +1.9% |
| Q3 2013 | $556,000 | +4.3% | 8,020 | -4.8% | 0.21% | -2.8% |
| Q2 2013 | $533,000 | – | 8,420 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |